ArticleActa diabetologica2023

No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.

Claudio Tiberti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.